CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1478.35-6.95 (-0.47 %)
PREV CLOSE () 1485.30
OPEN PRICE () 1486.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23220
TODAY'S LOW / HIGH ()1475.10 1491.00
52 WK LOW / HIGH ()935 1519
NSE1478.65-7.8 (-0.52 %)
PREV CLOSE() 1486.45
OPEN PRICE () 1491.00
BID PRICE (QTY) 1478.65 (139)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1393334
TODAY'S LOW / HIGH() 1475.20 1492.55
52 WK LOW / HIGH ()935 1519
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Website : www.cipla.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
22May Cipla gets USFDA’s final nod for Lanre
Cipla and its wholly owned subsidiary Cipla USA Inc have received the fi..
22May Cipla rises on getting USFDA’s final n
Cipla is currently trading at Rs. 1457.80, up by 14.60 points or 1.01% f..
22May Cipla informs about disclosure
In compliance with the provisions of Regulation 30 of the Securities and..
16May Cipla inks pact to make additional inv
Cipla has signed definitive agreements for further investment of up to R..
15May Exide Industries, Infosys and Jindal S
Exide Industries has invested Rs 74.99 crore by way of subscription in t..
Financials
in Millions
QTR Mar 24 ANNUAL 24
Net Profit1038440772.5
Gross Profit 12242.4 49469.7
Operating Profit 1366555548.1
Net Sales 40366.6165743.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 6441.05 (7.14%)
M.Cap ( in Cr)
16102.63
Divi's Lab (BSE)
 4254.00 (3.18%)
M.Cap ( in Cr)
112930.33
JB Chem & Pharma (BSE)
 1781.70 (6.79%)
M.Cap ( in Cr)
27652.25
Glenmark Pharma (BSE)
 1120.30 (8.20%)
M.Cap ( in Cr)
31613.54
Pfizer (BSE)
 4552.90 (1.33%)
M.Cap ( in Cr)
20828.48
Shareholding Pattern
PROMOTERS 33.47%
MUTUAL FUNDS/UTI 16.83%
NON-INSTITUTION 16.36%
FI/BANKS/INSURANCE 5.49%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75390.50-19.89 (-0.03%)
NIFTY22932.45-24.65 (-0.11%)
Dow Jones 39069.594.33 (0.01%)
Nasdaq 16920.79184.76 (1.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI